Urologic oncology Journal

•  
• Identity
•  
• Other
•  
• View All
•  

Identity

International Standard Serial Number (ISSN)

• 1078-1439

Other

publication venue for

• Phase II studies of antiangiogenic four drug regimens for the treatment of advanced renal cell carcinoma: FUNIL-retinoid and the FUNIL-thalidomide protocols..  26:610-615.